Your session is about to expire
← Back to Search
Local Anesthetic
Erector Spinae Nerve Block for Thoracic Surgery
Phase 4
Waitlist Available
Led By Charles Luke, MD
Research Sponsored by Neal Shah, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-120 hours post-operative
Awards & highlights
Study Summary
This trial will compare the efficacy, safety, and side-effect profile of continuous erector spinae plane analgesia (ESP) versus continuous paravertebral analgesia (PVB) for video-assisted thoracic surgery (VATS).
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0-120 hours post-operative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-120 hours post-operative
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient Reported Pain Scores
Total Opioid Consumption
Secondary outcome measures
Amount Achieved on Incentive Spirometer
Averaged Total of Narcotic Usage
Length of Hospital Stay
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Paravertebral Nerve BlockExperimental Treatment1 Intervention
Paravertebral nerve block
Group II: Erector Spinae Nerve BlockExperimental Treatment1 Intervention
Erector Spinae nerve block
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Paravertebral nerve block
2019
Completed Phase 4
~40
Erector Spinae nerve block
2019
Completed Phase 4
~40
Find a Location
Who is running the clinical trial?
Neal Shah, MDLead Sponsor
Charles LukeLead Sponsor
Nicholas Schott, MDStudy DirectorUniversity of Pittsburgh
Share this study with friends
Copy Link
Messenger